ORCOSA Inc Email Format
Biotechnology ResearchNew Jersey, United States11-50 Employees
Orcosa Inc is a biotechnology research company based in Ewing, New Jersey. It is developing the Rapid Infusion Technology Platform to enable fast-acting, easy-to-take formulations that improve drug absorption and patient outcomes. Its first product candidate, ORAVEXX, is a non-addictive cannabidiol composition that uses the RITe Platform to treat pain and offer an alternative to opioids. The company operates a cGMP-compliant manufacturing facility in the United States and collaborates with research institutions and physicians to support FDA-authorized investigator-initiated trials evaluating CBD for pain and inflammation. Orcosa is a small to mid-sized life sciences company focused on advances in therapeutic delivery. In May 2026, the company announced leadership changes, naming Andy Drechsler as Chief Financial Officer and appointing a co-founder as Chief Executive Officer.